GENEVA (AP) — Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States ...

Swiss drugmaker Roche (RHHBY) announced its decision to invest $50 billion in the U.S. towards pharmaceuticals and diagnostics over the next ...

The investment plans include new R&D sites in four US states and creating more than 12,000 jobs, according to the Swiss pharmaceutical company. View on euronews ...

Swiss drugmaker Roche said it plans to invest $50 billion in the U.S., the latest in a string of large companies boosting ...

Executives at Swiss-based Roche predict the drug maker is better off than other pharmaceutical companies as it had shifted ...

The pharma giant said the investment would create more than 12,000 jobs, as it joins rival Novartis in expanding its ...

Roche promised that its investments in the U.S. means it will export more medicines than it imports in the U.S.

Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff exemptions, arguing the products ...

Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by breast cancer drug Phesgo ...

The Basel-based company said the investment would go toward high-tech research and development sites and new manufacturing ...

GENEVA (AP) — Swiss pharmaceuticals powerhouse Roche announced Monday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs. The Basel-based company ...

INDIANAPOLIS — Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs. The Basel-based company, ...